www.public4you.fora.pl

njlpkhgea

Successful combination of drugs to prevent HIV infection in monkeys

In the forecast. They found that HIV infected patients with virus subgroup D than in A subgroup of patients infected with more likely to die. 10% of the D sub-class dead in 3 years infected, and infected with subtypes A no deaths. However,[link widoczny dla zalogowanych], the two sub-classes of viral load in the range 2O, 0oO-i00, 000 grains / cubic ml of blood, there was no time frame to find the same accurate prediction of rapid death. A sub-class of analog sub-D more toxic, because the D sub-class can bind a key receptors on immune cells, so that sub-class of anti-D more capable. In addition. A type of blood analysis showed the virus to bind a receptor is only one - CCR5, to infect cells. However, 25% of the D sub-class of viruses bound CCR5 and another receptor ---- CXCR4. In fact,[link widoczny dla zalogowanych], these binding CXCR4 virus have 2 / 3 deaths in 3 years. About a person's HIV viral type is important for the treatment. Study found that sub-category D with D virus and recombinant virus infection in sub-class of more rapid expansion, which will help the treatment of HIV infection. Fortunately, a successful combination of drugs to prevent HIV infection of monkeys space network in February, according to medical 1O reported in monkeys into two common AIDS drugs that can effectively protect monkeys from HIV infection. The Valley CDC and other man-made internal Dehe called TRUVADA monkeys injected compound preparation, the preparation containing emtricitabine and tenofovir these two drugs. Cocktail of drugs to treat AIDS often used in this preparation. Scientists simulate sexual intercourse the way gay men,[link widoczny dla zalogowanych], injection through the rectum to the monkeys This is from the Scientists consecutive 14 days into this every day for the monkey virus, but also for the monkeys injected with the drug. Six monkeys received all drug injection mixture from HIV infection. This finding may provide by far the most powerful animal data, suggesting that effective anti-retroviral drugs to prevent HIV may be transmitted through sex. But they also noted that the results apply to humans. Further research is needed to answer. Fortunately, a new German progress in the treatment of AIDS Research Network in January, according to medical space 1O reported,[link widoczny dla zalogowanych], is currently being studied in a combination therapy,[link widoczny dla zalogowanych], is expected to open new avenues for HIV treatment. There are also preliminary results of a new vaccine well, about to enter Phase II trials. Scientists are now using a traditional treatment of AIDS drugs and other epilepsy drugs, a treatment combination therapy studies. Trial, 4 subjects had 3 in the human body's lymphocytes previously dormant HIV virus is activated, allowing drugs to their work. Scientists say the drug had essentially dormant virus that can not attack, and the new results are the first to find an effective way to deal with them. A combination of the effectiveness of two vaccines developed for a new type of vaccine. Will be held this year in Africa and the Americas and other places of the 12 research centers also conduct Phase II trials, a total of about 1,000 people will participate in trials. Using this vaccine in a trial, the vaccine produced by different levels of antibodies in vivo, and demonstrate the effective cellular immune response. Now scientists are facing a good opportunity, is expected to eventually find a cure for AIDS cure. Nevertheless, some experts cautious. That there is no existing research breakthroughs. . 14.